SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53
http://www.w3.org/2000/01/rdf-schema#comment
"TIMP-1 confers resistance to treatment with the widely used topoisomerase inhibitors in breast and colorectal cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_1756192C82A50AC14C9F08D675F5B3BF5DE2424321D84C0E78F9C73B2F812AE8C2B5CF6D64273ABFE10C45AFD8844800
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53
http://purl.uniprot.org/uniprot/P01033
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53
http://purl.uniprot.org/uniprot/#_P01033-mappedCitation-23909892
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/21C226F0F0FC7A61AD3DC93C0C76846EDC0A244F7DB32B39E9B4D3AAF4E139846586CCA025B112C595AE6FB3A1C63D53